Chromosomally and microsatellite stable colorectal carcinomas without the CpG island methylator phenotype in a molecular classifcationOSTWALD, Christiane; LINNEBACHER, Michael; WEIRICH, Volker et al.International journal of oncology. 2009, Vol 35, Num 2, pp 321-327, issn 1019-6439, 7 p.Article

Microdensitometry of osteopontin as an immunohistochemical prognostic biomarker in colorectal carcinoma tissue microarrays: potential and limitations of the method in 'biomarker pathology'PRALL, Friedrich; MALETZKI, Claudia; LINNEBACHER, Michael et al.Histopathology. 2012, Vol 61, Num 5, pp 823-832, issn 0309-0167, 10 p.Article

Lysates of S. pyogenes Serotype M49 Induce Pancreatic Tumor Growth Delay by Specific and Unspecific Antitumor Immune ResponsesLINNEBACHER, Michael; MALETZKI, Claudia; EMMRICH, Jorg et al.Journal of immunotherapy (1997). 2008, Vol 31, Num 8, pp 704-713, issn 1524-9557, 10 p.Article

Intranasal immunization with human papillomavirus type 16 capsomeres in the presence of non-toxic cholera toxin-based adjuvants elicits increased vaginal immunoglobulin levelsDELL, Kerstin; KOESTERS, Robert; LINNEBACHER, Michael et al.Vaccine. 2006, Vol 24, Num 13, pp 2238-2247, issn 0264-410X, 10 p.Article

WT1 is a tumor-associated antigen in colon cancer that can be recognized by in vitro stimulated cytotoxic T cellsKOESTERS, Robert; LINNEBACHER, Michael; COY, Johannes F et al.International journal of cancer. 2004, Vol 109, Num 3, pp 385-392, issn 0020-7136, 8 p.Article

Frameshift-derived neoantigens constitute immunotherapeutic targets for patients with microsatellite-instable haematological malignancies: Frameshift peptides for treating MSI⁺ blood cancersMALETZKI, Claudia; SCHMIDT, Fabian; DIRKS, Wilhelm G et al.European journal of cancer (1990). 2013, Vol 49, Num 11, pp 2587-2595, issn 0959-8049, 9 p.Article

Expression of an endogenous retroviral sequence from the HERV-H group in gastrointestinal cancersWENTZENSEN, Nicolas; COY, Johannes F; KNAEBEL, Hanns-Peter et al.International journal of cancer. 2007, Vol 121, Num 7, pp 1417-1423, issn 0020-7136, 7 p.Article

Compound heterozygosity for two MSH6 mutations in a patient with early onset of HNPCC-associated cancers, but without hematological malignancy and brain tumorPLASCHKE, Jens; LINNEBACHER, Michael; KLOOR, Matthias et al.European journal of human genetics. 2006, Vol 14, Num 5, pp 561-566, issn 1018-4813, 6 p.Article

Identification of an HLA-A0201-restricted CTL epitope generated by a tumor-specific frameshift mutation in a coding microsatellite of the OGT geneRIPBERGER, Eva; LINNEBACHER, Michael; SCHWITALLE, Yvette et al.Journal of clinical immunology. 2003, Vol 23, Num 5, pp 415-423, issn 0271-9142, 9 p.Article

Prevention of chemotherapy-related toxic side effects by infection with adeno-associated virus type 2EISOLD, Sven; DIHLMANN, Susanne; LINNEBACHER, Michael et al.International journal of cancer. 2002, Vol 100, Num 5, pp 606-614, issn 0020-7136Article

Frameshift peptide-derived T-cell epitopes: A source of novel tumor-specific antigensLINNEBACHER, Michael; GEBERT, Johannes; RUDY, Wolfgang et al.International journal of cancer. 2001, Vol 93, Num 1, pp 6-11, issn 0020-7136Article